Differential control of expression of type I and type II receptors of transforming growth factor-β in colon carcinoma cells

Journal of Cellular Physiology

Volumn 168, Issue 3, 1996, Pages 711-720

  Periyasamy, Sumudra ^a   Sun, Luzhe ^a,b   Gentry, Larry E ^a   Brattain, Michael G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DACTINOMYCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; COLON CARCINOMA; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE;

EID: 0029785664     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4652(199609)168:3<711::aid-jcp24>3.0.co;2-%23     Document Type: Article

References (45)

1. 1 can induce estrogen independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4:193-201.
2. Bassing, C.H., Yingling, J.M., Howe, D.J., Wang, T., He, W.W., Gustafson, M.L., Shah, P., Dohnahoe, P.K., and Wang, X.-F. (1994) A transforming growth factor β type 1 receptor that signals to activate gene expression. Science, 263:87-89.
3. Brattain, M.G., Brattain, D.E., Fine, W.D., Khaled, F.M., Marks, M.E., Arcolano, L.A., and Danbury, B.H. (1981) Initiation of cultures of human colon carcinoma with different biological properties on confluent fibroblasts. Onco. Dev. Biol. Med., 2:355-367.
4. Brattain, M.G., Levine, A.E., Chakrabarty, S., Yeoman, L.C., Wilson, J.K.V., and Long, B.H. (1984) Heterogeneity of human colon carcinoma. Cancer Metastasis Rev., 3:177-191.
5. Centrella, M., McCarthy, T.L., and Canalis, E. (1988) Parathyroid hormone modulates transforming growth factor β activity and binding in osteoblastic cells. Proc. Natl. Acad. Sci. USA, 85:5889-5893.
6. Chakrabarty, S., Tobon, A., Varani, J., and Brattain, M.G. (1988) Induction of carcinoembryonic antigen secretion and modulation of protein secretion expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-β. Cancer Res., 48:4059-4064.
7. Chen, R.-H., and Derynck, R. (1994) Homomeric interactions between type II transforming growth factor-β receptor. J. Biol. Chem., 269:22868-22874.
8. Cochet, C., Feige, J.-J., and Chambaz, E.M. (1988) Bovine adreno cortical cells exhibit high affinity transforming growth factor-β receptors which are regulated by adreno-corticotropin. J. Biol. Chem., 263:5707-5713.
9. Franzen, P., Ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. (1993) Identification of a TGF-β type 1 receptor as a novel member of the serine/threonine kinase receptor family. Cell, 75:681-692.
10. Frolik, C.A., Wakefield, L.M., Smith, D.M., and Sporn, M.B. (1984) Characterization of a membrane receptor for transforming growth factor-β in normal kidney fibroblasts. J. Biol. Chem., 259:10995-11000.
11. Henis, Y.I., Moustakas, A., Lin, H.Y., and Lodish, H.F. (1994) The types II and III transforming growth factor-β receptors form homooligomers. J. Cell Biol., 126:139-154.
12. Hoosein, N.M., Brattain, D.E., McKnight, M.K., Levine, A.E., and Brattain, M.G. (1987) Characterization of the inhibitory effects of transforming growth factor-β on a human colon carcinoma cell line. Cancer Res., 47:2950-2954.
13. Kadin, M.E., Cavaille-Coll, M.W., Gertz, R., Massague, J., Cheifetz, S., and George, D. (1994) Loss of receptors for transforming growth factor-β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA, 91:6002-6006.
14. Kalkhoven, E., Roelen, B.A.J., Winter, J.P.D., Mummery, C.L., Van den Eijnden-Van Raaij, A.J.M., Van der Saag, P.T., and Van der Burg, B. (1995) Resistance to transforming growth factor-β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ., 6:1151-1116.
15. Kyprianou, N., and Isaacs, J.T. (1988) Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology, 123:2124-2131.
16. Laiho, M., Weiss, F.M.B., and Massague, J. (1990) Concomitant loss of transforming growth factor (TGF-)-β receptor types I and II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem., 265:18518-18524.
17. Laiho, M., Weiss, F.M.B., Boyd, F.T., Ignotz, L.A., and Massague, J. (1991) Responsiveness to transforming growth factor-β restored by complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem., 266:9108-9112.
18. Lin, H.Y., and Lodish, H.F. (1993) Receptors for the TGF-β superfamily: Multiple polypeptides and serine/threonine kinases. Trends Cell Biol., 3:14-19.
19. Lin, H.Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R.A., and Lodish, H.F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine threonine kinase. Cell, 68:775-785.
20. Lopez-Casillas, F., Wrana, J.L., and Massague, J. (1993) Betaglycan presents ligand to the TGF-β signalling receptor. Cell, 73:1435-1444.
21. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L.-Z., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Volgelstein, B., Brattain, M.G., and Willson, J.K.V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268:1336-1338.
22. Massague, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol., 6:597-641.
23. Massague, J. (1992) Receptors for the TGF-β family. Cell, 69:1067-1070.
24. Miyazono, K., ten Dijke, P., Ichijo, H., and Heldin, C.H. (1994) Receptor for transforming growth factor-β. Adv. Immunol., 55:181-220.
25. Moren, A., Ichijo, H., and Miyazono, K. (1992) Molecular cloning and characterization of the human and porcine transforming growth factor-β type III receptors. Biochem. Biophys. Res. Commun., 189:356-362.
26. Mulder, K.M., and Brattain, M.G. (1988) Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells. Int. J. Cancer, 42:64-70.
27. Mulder, K.M., and Brattain, M.G. (1989) Effects of growth stimulating factors on mitogenicity and c-myc expression in poorly-differentiated and well-differentiated human colon carcinoma cells. Mol. Endocrinol., 3:1215-1222.
28. Mulder, K.M., Levine, A.E., Hernandez, X.H., McKnight, M.K., Brattain, D.E., and Brattain, M.G. (1988a) Modulation of c-myc by transforming growth factor-β in human colon carcinoma cells. Biochem. Biophysics. Res. Commun., 150:711-716.
29. Mulder, K.M., Ramey, M.K., Hoosein, N.M., Levine, A.E., Hinshaw, X.H., Brattain, D.E., and Brattain, M.G. (1988b) Characterization of transforming growth factor-β-resistant subclones isolated from a transforming growth factor-β-sensitive human colon carcinoma cell line. Cancer Res., 48:7120-7125.
30. Muller, G.A., Behrens, J., Nussbaumer, U., Bohlen, P., and Birchmeier, W. (1987) Inhibitory action of transforming growth factor-β on endothelial cells. Proc. Natl. Acad. Sci. USA, 84:5600-5604.
31. Myeroff, L.L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K.R., Orth, K., Mathis, M., Kinzler, K.W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H.Y., Park, J.-G., Lynch, H.T., Roberts, A.B., Vogelstein, B., and Markowitz, S.D. (1995) A transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55:5545-5547.
32. Newman, W., Beall, L.D., Bertolini, D.R., and Cone, J.L. (1989) Modulation of TGF-β type I receptor: Flow cytometric detection with biotinylated TGF-β. J. Cell Physiol., 141:170-180.
33. Park, K., Kim, S.J., Bang, Y.J., Park, J.G., Kim, N.Y., Roberts, A.B., and Sporn, M.B. (1994) Genetic changes in TGF-β type II receptor gene in human gastric cancer cells; Correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91:8772-8776.
34. Rizzino, A., Kazakoff, P., Ruff, E., Kuszynski, C., and Nebelsick, J. (1988) Regulatory effects of cell density on the binding of transforming growth factor-β, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. Cancer Res., 48:4266-4271.
35. Roberts, A.B., and Sporn, M.B. (1990) The transforming growth factor-betas. In: Peptide Growth Factors and Their Receptors. M.B. Sporn, and A.B. Roberts, eds. Springer-Verlag, Heidelberg, pp. 419-472.
36. 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Exp. Cell. Res., 214:215-224.
37. Sun, L.-Z., Wu, G., Willson, J.K.V., Zborowska, E., Yang, J.-H., Rajakarunanayake, I., Wang, J., Gentry, L.E., Wang, X.-F., and Brattain, M.G. (1994b) Expression of transforming growth factor-β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269:26449-26455.
38. Wakefield, L.M., Smith, D.M., Masui, T., Harris, C.C., and Sporn, M.B. (1987) Distribution and modulation of the cellular receptor for transforming growth factor-β. J. Cell Biol., 105:965-975.
39. Wang, J., Sun, L.-Z., Myeroff, L., Wang, X.-F., Gentry, L.E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J.K.V., and Brattain, M.G. (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270:22044-22049.
40. Wang, X.-F., Lin, H.Y., Ng-Eaton, E., Downward, J., Lodish, H.F., and Weinberg, R.A. (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell, 67:797-805.
41. Wrana, J.L., Attisano, L., Caramo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., and Massague, J. (1992) TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71:1003-1014.
42. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994) Mechanism of activation of the TGF-β receptors. Nature, 370:341-347.
43. 1 is an autocrine negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an anti-sense expression vector. J. Cell Biol., 116:187-196.
44. 2 in quiescent CBS colon carcinoma cells lead to progression of tumorigenic properties. Cell Growth Differ., 4:115-123.
45. Zhou, G.-H.K., Sechrist, G.L., Periyasamy, S., Brattain, M.G., and Mulder, K.M. (1995) Transforming growth factor β isoform-specific differences in interactions with type I and II transforming growth factor β receptors. Cancer Res., 55:2056-2062.